BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7378926)

  • 1. Influence of dietary portein on the disposition and metabolism of phenylbutazone in rats.
    Varma DR
    Can J Physiol Pharmacol; 1980 Mar; 58(3):231-6. PubMed ID: 7378926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of phenylbutazone in man.
    Dieterle W; Faigle JW; Früh F; Mory H; Theoblad W; Alt KO; Richter WJ
    Arzneimittelforschung; 1976 Apr; 26(4):572-7. PubMed ID: 782467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of phenylbutazone in rats.
    Alexander DM; Mathew GE; Wilson BJ
    Xenobiotica; 1985 Feb; 15(2):123-8. PubMed ID: 4002734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dietary protein on the anti-inflammatory and ulcerogenic effects and on the pharmacokinetics of phenylbutazone in rats.
    Varma DR
    J Pharmacol Exp Ther; 1979 Nov; 211(2):338-44. PubMed ID: 115991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography.
    Marunaka T; Shibata T; Minami Y; Umeno Y
    J Chromatogr; 1980 Sep; 183(3):331-8. PubMed ID: 7419650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the absorption, excretion, and metabolism of suxibuzone and phenylbutazone in humans.
    Yasuda Y; Shindo T; Mitani N; Ishida N; Oono F; Kageyama T
    J Pharm Sci; 1982 May; 71(5):565-72. PubMed ID: 7097505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
    Mills PC; Ng JC; Auer DE
    J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, metabolism and disposition of salicylate in protein-deficient rats.
    Yue TL; Varma DR
    Drug Metab Dispos; 1982; 10(2):147-52. PubMed ID: 6124400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse.
    Lees P; Taylor JB; Maitho TE; Millar JD; Higgins AJ
    Cornell Vet; 1987 Apr; 77(2):192-211. PubMed ID: 3568689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.
    Tobin T; Blake JW; Valentine R
    Am J Vet Res; 1977 Jan; 38(1):123-7. PubMed ID: 835859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition and oxidative metabolism of phenylbutazone in man.
    Aarbakke J; Bakke OM; Milde EJ; Davies DS
    Eur J Clin Pharmacol; 1977; 11(5):359-66. PubMed ID: 880975
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenylbutazone and its metabolites in plasma and urine of thoroughbred horses: population distributions and effects of urinary pH.
    Houston T; Chay S; Woods WE; Combs G; Kamerling S; Blake JW; Edmundson AG; Vessiney R; Tobin T
    J Vet Pharmacol Ther; 1985 Jun; 8(2):136-49. PubMed ID: 4020945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of phenylbutazone in two age groups of ponies: a preliminary study.
    Lees P; Maitho TE; Taylor JB
    Vet Rec; 1985 Mar; 116(9):229-32. PubMed ID: 4002593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of phenylbutazone elimination by its metabolite oxyphenbutazone.
    Jähnchen E; Levy G
    Proc Soc Exp Biol Med; 1972 Dec; 141(3):963-5. PubMed ID: 4645785
    [No Abstract]   [Full Text] [Related]  

  • 15. A chronic dose-ranging study of the pharmacokinetics of phenylbutazone in rheumatoid arthritic patients.
    Higham C; Aarons L; Holt PJ; Lynch M; Rowland M
    Br J Clin Pharmacol; 1981 Aug; 12(2):123-9. PubMed ID: 7306426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration.
    Lees P; Ayliffe T; Maitho TE; Taylor JB
    Res Vet Sci; 1988 Jan; 44(1):57-67. PubMed ID: 3375589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of tobacco on the serum levels and pharmacokinetics of phenylbutazone and oxyphenbutazone].
    Queneau P; Ollagnier M; Decousus H; Perpoint B; Brazier JL; Faucon L
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):293-7. PubMed ID: 6879097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of phenylbutazone in camels.
    Wasfi IA; Abdel Hadi AH; Zorob O; Osman M al-G ; Boni NS
    Am J Vet Res; 1997 Jun; 58(6):636-40. PubMed ID: 9185972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylbutazone and oxyphenbutazone distribution into tissue fluids in the horse.
    Lees P; Taylor JB; Higgins AJ; Sharma SC
    J Vet Pharmacol Ther; 1986 Jun; 9(2):204-12. PubMed ID: 3723663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.